Dr Anita Sveen received the Young Investigator prize at Onkologisk Forum for her research accomplishments
Anita Sveen received the YI prize worth 50,000 NOK at Onkologisk Forum, the annual meeting for oncologists, for her research accomplishments on computational oncology.
Dr. Sveen presented her research in computational oncology focusing on clinical relevant questions for colorectal cancer and novel results published in 6 selected papers:
Sveen et al., Clin Cancer Res 2012
Ågesen, Sveen et al., GUT, 2012
Sveen, Løes et al., PloSGenet 2016
Sveen, Johannessen, Tengs et al., Genome Medicine 2017
Sveen, Bruun et al., Clinic Cancer Res, in press accepted last week.
“Colorectal cancer Consensus Molecular Subtypes translated to preclinical models uncover potentially targetable cancer-cell dependencies”
Anita Sveen is a scientist in the Lothe group at the Department of Molecular Oncology. Her research focus is on computational oncology of colorectal cancer, involving multi-level genomic analyses of primary and metastatic cancers in translational research projects. By integration of genomic data at different levels, the aim is to determine the clinical importance of tumor heterogeneity, both with respect to prognostic assessment of the patients and prediction of treatment response. Current research projects include analyses of tumor heterogeneity within and among tumors from individual patients, during metastatic progression, as well as within the biologically distinct subgroups of colorectal cancer.
Latest publicationsBurocziova et al. 2019. Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon. Cell Death. Dis. 10(11): 818
Eilertsen et al. 2019. Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer. Cancer Lett. [Epub ahead of print] Lopes et al. 2019. Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2. Lab. Invest. [Epub ahead of print] Dienstmann et al. 2019. Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer. Ann. Oncol. [Epub ahead of print] Totland et al. 2019. Regulation of gap junction intercellular communication by connexin ubiquitination: physiological and pathophysiological implications. Cell. Mol. Life Sci. [Epub ahead of print] All publications